A 153 (Nifedipine extended release 30 mg)
Pill imprint A 153 has been identified as Nifedipine extended release 30 mg.
Nifedipine is used in the treatment of high blood pressure; raynaud's syndrome; hypertensive emergency; angina pectoris prophylaxis; heart failure (and more), and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nifedipine 30 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for A 153 (Nifedipine extended release 30 mg)
- Imprint:
-
A
153 - Strength:
- 30 mg
- Color:
- Yellow
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Calcium channel blocking agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Actavis
- National Drug Code (NDC):
- 67767-0153
- Inactive Ingredients:
- silicon dioxide
hypromelloses
lactose monohydrate
magnesium stearate
polydextrose
polyethylene glycol 8000
triacetin
ferric oxide yellow
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0142 | Amerisource Health Services |
| 63739-0451 | McKesson Packaging Services |
| 67544-1136 | Prepak Systems Inc (repackager) |
| 21695-0908 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
More resources
Nifedipine extended release is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
